Jeil Pharma Holdings Inc (KRX:002620)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,200.00
-20.00 (-0.28%)
Oct 23, 2026, 3:30 PM KST

Jeil Pharma Holdings Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
630,891657,614779,822804,043792,965762,568
Revenue Growth
-14.26%-15.67%-3.01%1.40%3.99%0.07%
Gross Profit
256,690253,498206,521214,584180,483180,507
Operating Income
18,61038,986-11,18120,920-7,548-8,975
Net Income
8,43514,635-51,159-16,250-74,556-3,482
Earnings Per Share
549.00953.00-3333.00-1059.00-4857.00-227.00
EPS Growth
------

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Pharmaceutical Sector
640,474663,203794,702818,400812,943778,722
Connection Adjustment
-24,623-20,432-29,532-28,044-31,592-28,073
Investment Division
15,04014,84314,65113,68711,61411,918
Total
630,891657,614779,822804,043792,965762,568

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
87,50579,31275,88359,13153,40347,224
Total Debt
184,738167,369155,212214,143162,616115,072
Net Cash (Debt)
-97,234-88,058-79,329-155,012-109,213-67,848
Net Cash Growth
------
Net Cash Per Share
-6333.98-5736.24-5167.62-10097.73-7114.36-4419.76

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
11,861390.264,542-4,416-17,25613,403
Capital Expenditures
-12,764-8,283-4,340-6,223-15,462-23,688
Free Cash Flow
-902.83-7,893202.38-10,638-32,717-10,284
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
40.69%38.55%26.48%26.69%22.76%23.67%
Operating Margin
2.95%5.93%-1.43%2.60%-0.95%-1.18%
Pretax Margin
3.91%5.99%-7.90%-1.74%-10.58%-0.80%
Profit Margin
1.34%2.23%-6.56%-2.02%-9.40%-0.46%
FCF Margin
-0.14%-1.20%0.03%-1.32%-4.13%-1.35%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
70.00070.00050.00050.00050.00065.000
Dividend Per Share Growth
40.00%40.00%0%0%-23.08%-7.14%
Dividend Yield
0.97%0.87%0.64%0.43%0.33%0.41%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
13.118.43----
P/FCF Ratio
--593.17---
PS Ratio
0.180.190.150.230.300.32